Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
This study has been completed.
Sponsor:
Memorial Sloan-Kettering Cancer Center
Collaborators:
Connective Tissue Oncology Society
M.D. Anderson Cancer Center
Massachusetts General Hospital
Mayo Clinic
University of Michigan Cancer Center
Information provided by:
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT00142571
First received: August 31, 2005
Last updated: October 1, 2007
Last verified: October 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2007 |
| Estimated Primary Completion Date: | No date given |